Freeline Therapeutics (NASDAQ:FRLN) reported quarterly losses of $(3.93) per share. This is a 42.29 percent increase over losses of $(6.81) per share from the same period last year.
Gilat Satellite Networks Q1 EPS $(0.04), Adj. EPS $(0.03) Up From $(0.09) YoY, Sales $51.40M Up From $43.37M YoY
Gilat Satellite Networks (NASDAQ: GILT) reported quarterly losses of $(0.04) per share. This is a 55.56 percent increase over losses of $(0.09) per share from the same period last year.
